Indrapr.Medical Share Price & Earnings Call Analysis

Financials of Indrapr.Medical

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Indrapr.Medical

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +274307317306315348350325334365381372365
Expenses +241259267259266281286273272292310310304
Operating Profit33475047486764526173716261
OPM %12%15%16%15%15%19%18%16%18%20%19%17%17%
Other Income +5444556567777
Interest1111222212211
Depreciation10101010101111111110111111
Profit before tax27404441426057455568665655
Tax %27%24%25%28%25%25%26%26%26%25%25%27%24%
Net Profit +20303329314542334151494142
EPS in Rs2.163.333.583.213.404.884.633.584.475.615.404.474.55

Financials of Indrapr.Medical

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +7147557667537888316138881,0991,2451,3561,483
Expenses +6306756866787067435727689471,0501,1121,216
Operating Profit85807974828741120152195245267
OPM %12%11%10%10%10%11%7%14%14%16%18%18%
Other Income +11-0-1-1-0-0-39162229
Interest878976334466
Depreciation283531313033333539404444
Profit before tax503941344548479117166216246
Tax %34%37%36%38%36%9%46%26%26%25%26%25%
Net Profit +32242621284425986124161184
EPS in Rs3.542.662.862.303.104.760.256.399.4013.5217.5620.03
Dividend Payout %51%68%63%65%52%0%0%39%32%33%26%20%

Financials of Indrapr.Medical

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital929292929292929292929292
Reserves103132139141152176181234288386505649
Borrowings +50526766214352343337
Other Liabilities +196185160134157177157131173212222214
Total Liabilities442460458432422449432462555723852991
Fixed Assets +286301296294280303283277275347328365
CWIP3300103030333
Investments000000000000
Other Assets +153157163138141146145185278376491624
Total Assets442460458432422449432462555723852991

Financials of Indrapr.Medical

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +6462284875862794144200157167
Cash from Investing Activity +-29-33-22-30-17-40-19-74-108-158-111-178
Cash from Financing Activity +-35-30-5-17-44-43-3-3-26-32-46-46
Net Cash Flow-0-0-01144517119-0-57
Free Cash Flow35295175846665100131120108
CFO/OP98%104%57%82%110%113%88%95%102%127%89%88%

Financials of Indrapr.Medical

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days404147413535401823172028
Inventory Days11
Days Payable182
Cash Conversion Cycle4041474135354018231720-144
Working Capital Days-35-22-17-7-5-10-1-2-12-24-19-4
ROCE %23%18%17%15%19%21%3%29%34%38%39%36%

Continue your research

Others in Healthcare Services this season

  • Manipal Health Enterprises Ltd (Q1 FY27)

    Volume-led growth with inpatient (IP) volumes up 39% and outpatient (OP) volumes up 26% year-on-year. Key concall takeaways from Manipal Health Enterprises…

  • Fortis Healthcare Ltd (Q1 FY27)

    IHH plans to increase its stake in Fortis to over 50% within 3-5 years, supporting long-term strategic growth. Key concall takeaways from Fortis Healthcare…

  • Metropolis Healthcare Ltd (Q1 FY27)

    East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…

  • Apollo Hospitals Enterprise Ltd (Q1 FY27)

    IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

Compare:vs Apollo Hospitals Enterprise Ltdvs Max Healthcare Institute Ltdvs Manipal Health Enterprises Ltd